Jesus Pacheco-Torres1, Tariq Shah1, William Nathaniel Brennen2, Flonne Wildes1, and Zaver M Bhujwalla1,2,3
1Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 2Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 3Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, United States
Synopsis
Fibroblasts play a pivotal role
in cancer progression. In prostate
cancer, fibroblasts have been shown to induce growth, confer
castration-resistance, and increase metastatic potential. To further understand how fibroblasts respond
to hypoxic tumor microenvironments
that are frequently observed in prostate cancer, here we have characterized the
effects of hypoxia on normal prostate fibroblast metabolites as detected by
high resolution 1H magnetic resonance spectroscopy. We
found that hypoxia induced metabolic changes in normal prostate fibroblasts that
mimicked the metabolites detected in prostate cancer associated fibroblasts
(CAFs), highlighting the potential role of hypoxia in the transition of normal
fibroblasts to CAFs.
Introduction
Fibroblasts are versatile cells that produce several extracellular
matrix (ECM) proteins such as collagen 1 and extradomain A containing
fibronectin, as well as degradative enzymes such as matrix metalloproteinases1. Fibroblasts play an important role in
wound healing, and in different pathological conditions such as the extensive
fibrosis observed in chronic conditions, and in cancer progression. Cancer associated fibroblasts (CAFs) are
directly involved in tumor progression and dissemination2-4. We recently identified increased CAFs in
more metastatic prostate cancers5. To understand the influence of hypoxia that
is frequently observed in prostate cancer in modifying fibroblast metabolism,
here we characterized human prostate fibroblast metabolites as detected by 1H
MRS under normoxic and hypoxic conditions and compared these to metabolites
detected in CAFs obtained from human prostate cancer. Methods
Experiments were performed
using human prostate fibroblasts (WPMY-1, ATCC, Manassas,
VA) and human prostate cancer associated fibroblasts (PCAFs, Asterand
Bioscience, Detroit, MI). WPMY-1 were
derived from stromal cells from the peripheral zone of the histologically
normal adult prostate6. PCAFs were obtained from an adenocarcinoma
of the prostate gland. In order to
induce hypoxia, WPMY-1 cells were incubated for 48h under hypoxic conditions (0%
O2) using an induction chamber where all the oxygen was displace by
100% N2 at the start of incubation. For high resolution 1H
MRS, cell extracts were obtained using a dual-phase extraction method as
previously described7. Water-soluble samples were dissolved in 0.6 mL
of buffered D2O (Sigma).
High-resolution 1H MR spectra were recorded on a Bruker
Biospin Avance-III 750 MHz NMR (Bruker Biospin) spectrometer operating at a
proton frequency of 750.21 MHz using a 5-mm broad band inverse (BBI) probe head
equipped with z-gradient accessories. 1H
MR spectra were manually phased and automated baseline corrected using TOPSPIN
3.2 software. Integrals of the
metabolites of interest were determined and normalized to the TSP reference and
the number of cells. Metabolites were
estimated from at least four experimental samples. Statistical significance
was evaluated using the Student t test.Results and discussion
We have previously observed
that hypoxia triggered significantly faster degradation of the ECM by
fibroblasts8. Here, we found
that a 48h incubation of normal prostate fibroblasts under hypoxia significantly
altered several metabolites making the spectra more similar to spectra obtained
from PCAFs under normoxic conditions, as shown in the representative spectra in
Figure 1. Significance metabolic
differences between normoxia and hypoxia, summarized in Figure 2, included
glutamine, glutamate, aspartate, alanine, choline (Cho), total creatine (TCr),
myo-inositol, reduced glutathione (GSH), glucose, S-methyl-5'-thioadenosine
(MTA), and ATP. The metabolic similarities
between normal WPMY-1 under hypoxia and PCAFs can be identified by comparing the
heat maps in Figures 3a and 3b. These data suggest that hypoxia plays an
important role in the metabolic transformation of fibroblasts to a malignant metabolic
phenotype. Future studies with normal fibroblasts
and CAFs obtained from different cancers should further validate the role of
hypoxia in the metabolic transformation identified in this study.Acknowledgements
This work was supported
by NIH R35CA209960 and R01CA82337. JPT
was funded by Fundación Alonso Martín Escudero and MSCA.References
1. Zent
J and Guo LW. Signaling Mechanisms of Myofibroblastic Activation: Outside-in
and Inside-Out. Cell Physiol Biochem. 2018; 49(3):848-868.
2. Glentis A, Oertle P, Mariani P, et
al. Cancer-associated fibroblasts induce metalloprotease-independent cancer
cell invasion of the basement membrane. Nat Commun. 2017; 8(1):924.
3. Labernadie A, Kato T, Brugues A, et
al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables
fibroblasts to drive cancer cell invasion. Nat Cell Biol. 2017; 19(3):224-237.
4. Valencia T, Kim JY, Abu-Baker S, et
al. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling
promotes inflammation and tumorigenesis. Cancer Cell. 2014; 26(1):121-135.
5. Penet MF, Kakkad S, Pathak AP, et
al. Structure and Function of a Prostate Cancer Dissemination-Permissive
Extracellular Matrix. Clin Cancer Res. 2017; 23(9):2245-2254.
6. Webber MM, Trakul N, Thraves PS, et
al. A human prostatic stromal myofibroblast cell line WPMY-1: a model for
stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis. 1999; 20(7):1185-92.
7. Penet MF, Shah T, Bharti S, et al.
Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline
metabolism. Clin Cancer Res. 2015; 21(2):386-95.
8. Pacheco-Torres
J, Shah T,. et al. Investigating the effects of hypoxia on fibroblast
invasion and metabolism. ISMRM 2019, abstract # 2300